Gene · 10521
NIH grants1,197
NIH grants whose papers are about the gene, through NIH's grant-paper links.
581 to 600 of 1,197
Download this page as JSON| Grant | Title | DDX17 papers | Newest fiscal year |
|---|---|---|---|
| R01CA182905 | Protein-coding and non-coding RNA biomarkers for early detection of CLL | 1 | 2018 |
| R01CA183459 | Targeting Mucin and EGFR Axis in Pancreatic Cancer | 1 | 2018 |
| R01CA184101 | MTDH regulates Fanconi anemia repair pathway to mediate drug resistance | 1 | 2018 |
| R01CA186568 | Spatially-resolved proteomic mapping of living cells | 1 | 2018 |
| R01CA188452 | Regulation of Hippo Signaling by Src-Family Kinases | 1 | 2018 |
| R01CA190696 | A New Treatment Paradigm for ALK-Driven Cancers Exploiting Oncogene Overdose | 1 | 2018 |
| R01CA196631 | A network platform to connect drug response and prognosis phenotypes for cancers | 1 | 2018 |
| R01DK084097 | ADPKD: understanding mechanisms and discovering treatments | 1 | 2018 |
| R01EY023962 | Pluripotent Stem Cell Vascular Therapies for Ischemic Retinopathies | 1 | 2018 |
| R01GM049369 | Function and regulation of the human splicing factor SC35 | 1 | 2018 |
| R01GM053007 | Pre-mRNA Splicing Mechanisms | 1 | 2018 |
| R01GM068414 | Regulation of RNA Metabolism by the RNA-dependent RNA Polymerase Activity of Mammalian RNA polymerase II | 1 | 2018 |
| R01GM076388 | Regulation of the ATR Checkpoint Kinase by DNA Damage | 1 | 2018 |
| R01GM079529 | Chemical Approaches to Mapping Cell Signaling Pathways | 1 | 2018 |
| R01GM086386 | Regulation of microRNA Biogenesis in Stem Cells | 1 | 2018 |
| R01GM113013 | Role of the ULK1 Complex in Autophagy | 1 | 2018 |
| R01GM121061 | Identification of Histone Deacetylase Substrates using Trapping Mutants | 1 | 2018 |
| R01HG004361 | Structural motifs in RNA | 1 | 2018 |
| R01HL122887 | Integrative Omics as a Discovery Tool for Pulmonary Hypertension | 1 | 2018 |
| R01MH105128 | Circuitry mechanisms underlying normal and aberrant adult hippocampal neurogenesis | 1 | 2018 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10521/grants?page=30